MiMedx Stock Forecast - 4 Period Moving Average

MDXG Stock  USD 9.12  0.04  0.44%   
The 4 Period Moving Average forecasted value of MiMedx Group on the next trading day is expected to be 9.04 with a mean absolute deviation of 0.29 and the sum of the absolute errors of 16.66. MiMedx Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of MiMedx's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At this time, MiMedx's Inventory Turnover is most likely to slightly decrease in the upcoming years. The MiMedx's current Fixed Asset Turnover is estimated to increase to 33.36, while Payables Turnover is projected to decrease to 3.26. . The current Common Stock Shares Outstanding is estimated to decrease to about 94.7 M. The MiMedx's current Net Loss is estimated to increase to about (31.4 M).

Open Interest Against 2025-03-21 MiMedx Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast MiMedx's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in MiMedx's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for MiMedx stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current MiMedx's open interest, investors have to compare it to MiMedx's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of MiMedx is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in MiMedx. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
A four-period moving average forecast model for MiMedx Group is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility.

MiMedx 4 Period Moving Average Price Forecast For the 19th of January

Given 90 days horizon, the 4 Period Moving Average forecasted value of MiMedx Group on the next trading day is expected to be 9.04 with a mean absolute deviation of 0.29, mean absolute percentage error of 0.19, and the sum of the absolute errors of 16.66.
Please note that although there have been many attempts to predict MiMedx Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that MiMedx's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

MiMedx Stock Forecast Pattern

Backtest MiMedxMiMedx Price PredictionBuy or Sell Advice 

MiMedx Forecasted Value

In the context of forecasting MiMedx's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. MiMedx's downside and upside margins for the forecasting period are 4.70 and 13.37, respectively. We have considered MiMedx's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
9.12
9.04
Expected Value
13.37
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of MiMedx stock data series using in forecasting. Note that when a statistical model is used to represent MiMedx stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria109.0942
BiasArithmetic mean of the errors -0.1462
MADMean absolute deviation0.2923
MAPEMean absolute percentage error0.0347
SAESum of the absolute errors16.6625
The four period moving average method has an advantage over other forecasting models in that it does smooth out peaks and troughs in a set of daily price observations of MiMedx. However, it also has several disadvantages. In particular this model does not produce an actual prediction equation for MiMedx Group and therefore, it cannot be a useful forecasting tool for medium or long range price predictions

Predictive Modules for MiMedx

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MiMedx Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
4.949.2713.60
Details
Intrinsic
Valuation
LowRealHigh
7.3511.6816.01
Details
5 Analysts
Consensus
LowTargetHigh
12.1913.4014.87
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.070.070.07
Details

Other Forecasting Options for MiMedx

For every potential investor in MiMedx, whether a beginner or expert, MiMedx's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. MiMedx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in MiMedx. Basic forecasting techniques help filter out the noise by identifying MiMedx's price trends.

View MiMedx Related Equities

 Risk & Return  Correlation

MiMedx Group Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of MiMedx's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of MiMedx's current price.

MiMedx Market Strength Events

Market strength indicators help investors to evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MiMedx shares will generate the highest return on investment. By undertsting and applying MiMedx stock market strength indicators, traders can identify MiMedx Group entry and exit signals to maximize returns.

MiMedx Risk Indicators

The analysis of MiMedx's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MiMedx's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mimedx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of MiMedx to cross-verify your projections.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.1)
Earnings Share
0.57
Revenue Per Share
2.447
Quarterly Revenue Growth
0.029
Return On Assets
0.1838
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.